Table 2.

Clinical profile of participants in the first-episode psychosis group

Clinical variables	Frequency (%)/mean (SD) (range)
Subtype of schizophrenia
Schizophreniaa	22 (73.3)
Othersb	8 (26.7)
Family history of mental illness
No	24 (80)
Yesc	6 (20)
Antipsychotic used
Risperidone	9 (30)
Olanzapine	18 (60)
Quetiapine	1 (3.3)
Aripiprazole	1 (3.3)
Trifluoperazine	1 (3.3)
Total duration of illness in months before starting medication (duration of untreated psychosis)	5.2 (3.9) (1-12)
Duration of treatment (months)	3.8 (1.2) (3-7)
Duration of current treatment (months)	3.8 (1.2) (3-7)
Duration of current remission (months)	3.3 (0.59) (3-5)
Positive and Negative Syndrome Scale
Positive subscale	13.0 (2.8) (8-18)
Negative subscale	13.8 (3.2) (7-19)
General psychopathology subscale	29.6 (6.4) (19-40)
Total score	56.3 (11.1) (39-74)

^aSchizophrenia: Subtypes included paranoid (n=20) and undifferentiated (n=2), ^bOther diagnoses included brief psychotic disorder (n=7) and psychosis not otherwise specified (n=1), ^cFamily history of mental illness included psychotic illness (n=3), affective disorder (n=1), anxiety disorder (n=1), mental retardation (n=1). SD – Standard deviation